Industry expert Yair Benita shows an example of target-based drug discovery, which relies on generating data from a ton of patients. In this example, researchers studied 10,000 patients and found a specific mutation in 40% of patients. They studied the gene and designed an inhibitor for a specific protein that led to a more than 30% reduction of tumor size in patients.

свернуть